Logistical challenges of CAR T-cell therapy in non-Hodgkin lymphoma: a survey of healthcare professionals-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Logistical challenges of CAR T-cell therapy in non-Hodgkin lymphoma: a survey of healthcare professionals

Published:2024-09-13 Issue: Volume: Page:1-14
ISSN:1479-6694
Container-title:Future Oncology
language:en
Short-container-title:Future Oncology

Author:

Sureda Anna¹,Adam Shiraz El²,Yang Shibing³,Griffin Evelyn²,Baker Jenny²,Johnston Karissa²,Navarro Fernando Rivas³,Alhasani Sarah³,Chhibber Anindit³,Wang Anthony⁴,Mutebi Alex³

Affiliation:

1. Institut Català d'Oncologia, Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain

2. Broadstreet HEOR, Vancouver, BC, Canada

3. Genmab US, Inc., Plainsboro, NJ, USA

4. Abbvie Inc., North Chicago, IL, USA

Funder

AbbVie

Genmab A/S

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14796694.2024.2393566

Reference23 articles.

1. CAR T-cell therapy for relapsed/refractory non-Hodgkin's lymphoma: a comprehensive review;St-Pierre F;Clin Adv Hematol Oncol.,2022

2. Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

3. Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial

4. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

5. Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP